Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchll-37cathelicidinoral cancerbiomarkers

Researchers probe salivary LL-37 as oral cancer biomarker

A Bioinformation study evaluates the cathelicidin peptide LL-37 in saliva as a non-invasive detection marker for oral cancer.

PR
By Priya Raman · Science Reporter
Jun 29 20:00 ETSource: Bioinformation

The wire

  1. 01Study examines salivary cathelicidin LL-37 as a non-invasive biomarker for detecting oral cancer.
  2. 02Saliva-based peptide markers could offer simpler screening than invasive diagnostic methods.
  3. 03Validation in larger cohorts and diagnostic accuracy details are not given in the source.

From the source

Salivary cathelicidin LL-37 as a non-invasive biomarker for oral cancer detection

Bioinformation · 2026 · Ravichandran T, B G H, Ganesan N et al.

Read at pubmed.ncbi.nlm.nih.gov